Continuous glucose monitoring effective with or without blood glucose monitoring measurement

In patients with Type 1 diabetes, having correct glucose levels is the first step in high quality care. A recent study, published in Diabetes Care, tested the effectiveness in continuous glucose monitoring (CGM) with and without blood glucose monitoring (BGM) measurement.

The clinical trial included participants from 14 different sites within the Type 1 diabetes Exchange Clinic Network. Participants were over 18 years old, have Type 1 diabetes, used an insulin pump and have a blood glucose level less than nine percent. The 26-week trial split participants into a CGM only group and CGM with BGM measurements.

Results showed that CGM use did not differ with or without BGM measurements. “Use of CGM without regular use of confirmatory BGM is as safe and effective as using CGM with BGM in well-controlled adults with T1D at low risk for severe hypoglycemia,” concluded first author on the study, Grazia Aleppo and colleagues. 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.